Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Rule 8.3- Cyprotex PLC

16 Mar 2010 18:10

RNS Number : 6968I
Mr G.L.A. Dow
16 March 2010
 



 

FORM 8.3

 

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

 

MR G L A DOW

 

Company dealt in

 

CYPROTEX

 

Class of relevant security to which the dealings being disclosed relate (Note 2)

 

ORDINARY SHARES

 

Date of dealing

 

12TH MARCH 2010

 

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

Number

(%)

Number

(%)

 

(1) Relevant securities

 

10,740,727

6.0%

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

10,740,727

6.0%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

 Class of relevant security:

Long

Short

Number

(%)

Number

(%)

 

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

 

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

 

 

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

 

 PURCHASE

500,000

3.75P

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product

name, e.g.

call option 

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option

relates

(Note 7)

Exercise

price

Type, e.g.

American,

European

etc.

Expiry

date

Option

money

paid/received

per unit (Note

5)

 

 

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

Is a Supplemental Form 8 attached? (Note 9)

YES/NO

 

 

Date of disclosure

 

16TH MARCH 2010

 

Contact name

 

G L A DOW

 

Telephone number

 

022 6005856 

If a connected EFM, name of offeree/offeror with which connected

 

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETVQLFFBXFBBBL
Date   Source Headline
14th Dec 20164:03 pmRNSScheme of Arrangement becomes effective
14th Dec 20167:30 amRNSSuspension - Cyprotex Plc
13th Dec 20163:32 pmRNSDirector Dealing
13th Dec 201611:46 amRNSCourt Sanction of Scheme of Arrangement
9th Dec 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Dec 201610:02 amRNSForm 8.5 (EPT/RI) Cyprotex plc
6th Dec 20169:04 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex Plc
5th Dec 20169:12 amRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:45 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:37 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20168:45 amRNSForm 8.3 - Cyprotex PLC
1st Dec 20161:40 pmRNSResults of Court Meeting & General Meeting
1st Dec 20169:08 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
1st Dec 20168:23 amRNSForm 8.3 - Cyprotex PLC
30th Nov 20169:06 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 201610:31 amRNSForm 8.3 - CYPROTEX PLC
29th Nov 20169:46 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 20167:00 amRNSLaunch of in vitro h-CLAT Service
28th Nov 201610:52 amRNSForm 8.3 - CYPROTEX PLC
28th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
25th Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex plc
23rd Nov 20169:17 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
22nd Nov 20169:05 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
21st Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
16th Nov 20169:24 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
15th Nov 20168:39 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
14th Nov 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
11th Nov 20167:00 amRNSDirector Dealing
10th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
9th Nov 20169:53 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
8th Nov 201610:01 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Nov 20169:27 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
4th Nov 20167:00 amRNSPosting of Scheme Document
2nd Nov 201610:09 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
1st Nov 20169:09 amRNSForm 8.5 (EPT/RI) Cyprotex
27th Oct 201612:39 pmRNSForm 8.5 (EPT/RI) CYPROTEX PLC
27th Oct 201610:11 amPRNForm 8.3 - Cyprotex Plc - Amendment
26th Oct 20169:08 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
26th Oct 20167:00 amRNSRule 2.7 Announcement: Recommended Offer
25th Oct 20169:23 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
21st Oct 20163:31 pmRNSDirector Declaration
21st Oct 20169:59 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
20th Oct 20168:57 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Oct 20169:22 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
14th Oct 20169:16 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20169:46 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20167:00 amRNSCyprotex PLC - Rule 2.9 Announcement
11th Oct 20169:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.